Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-centered Development and Effectiveness of Online Acceptance and Commitment Therapy for Pain Interference in Cancer Survivors With Persistent Painful Chemotherapy-induced Neuropathy

NCT05371158 is registered in ClinicalTrials.gov with Daniëlle van de Graaf as lead sponsor.

NCT NCT05371158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05371158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-centered Development and Effectiveness of Online Acceptance and Commitment Therapy for Pain Interference in Cancer Survivors With Persistent Painful Chemotherapy-induced Neuropathy
Lead sponsor
Daniëlle van de Graaf
Phase
Not applicable
Overall status
Terminated
Start date
December 1, 2021
Completion date
July 1, 2024
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer survivors, chemotherapy-induced peripheral neuropathy